Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-044157
Filing Date
2025-05-15
Accepted
2025-05-15 16:01:50
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241477-10q_biomxinc.htm   iXBRL 10-Q 640950
2 CERTIFICATION ea0241477ex31-1_biomxinc.htm EX-31.1 8213
3 CERTIFICATION ea0241477ex31-2_biomxinc.htm EX-31.2 8177
4 CERTIFICATION ea0241477ex32_biomxinc.htm EX-32 5529
  Complete submission text file 0001213900-25-044157.txt   5021647

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE phge-20250331.xsd EX-101.SCH 48539
6 XBRL CALCULATION FILE phge-20250331_cal.xml EX-101.CAL 38305
7 XBRL DEFINITION FILE phge-20250331_def.xml EX-101.DEF 253609
8 XBRL LABEL FILE phge-20250331_lab.xml EX-101.LAB 442662
9 XBRL PRESENTATION FILE phge-20250331_pre.xml EX-101.PRE 270359
72 EXTRACTED XBRL INSTANCE DOCUMENT ea0241477-10q_biomxinc_htm.xml XML 483179
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 25952418
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)